Journal of Infection and Public Health
Volume 2, Issue 3 , Pages 141-146, 2009

Improvement in vancomycin utilization in adults in a Saudi Arabian Medical Center using the Hospital Infection Control Practices Advisory Committee guidelines and simple educational activity

  • Jean G. Dib

      Affiliations

    • Pharmacy Services Division, Saudi Aramco Medical Services Organization (SAMSO), Saudi Aramco, Saudi Arabia
  • ,
  • Jaffar A. Al-Tawfiq

      Affiliations

    • Internal Medicine Services Division, Saudi Aramco Medical Services Organization (SAMSO), Saudi Aramco, Saudi Arabia
    • Corresponding Author InformationCorresponding author at: P.O. Box 76, Rm A-428-2, Building 61, Dhahran Health Center, Saudi Aramco, Dhahran 31311, Saudi Arabia. Tel.: +966 3 877 3524; fax: +966 3 877 3790.
  • ,
  • Saud Al Abdulmohsin

      Affiliations

    • Pharmacy Services Division, Saudi Aramco Medical Services Organization (SAMSO), Saudi Aramco, Saudi Arabia
  • ,
  • Khurram Mohammed

      Affiliations

    • Pharmacy Services Division, Saudi Aramco Medical Services Organization (SAMSO), Saudi Aramco, Saudi Arabia
  • ,
  • Phyllis D. Jenden

      Affiliations

    • Pharmacy Services Division, Saudi Aramco Medical Services Organization (SAMSO), Saudi Aramco, Saudi Arabia

Received 16 February 2009; received in revised form 30 June 2009; accepted 2 July 2009.

Summary 

Objective

To evaluate vancomycin utilization according to the adapted criteria of the Centers for Disease Control and Prevention (CDC) with a report of the effect of education program on the utilization.

Method

We evaluated the utilization of vancomycin over a 3-month period pre- and post-intervention using educational activity.

Results

In the pre-intervention period, of the 74 adult patients vancomycin was prescribed for specific treatment in 66% (n=49), empirical therapy in 26% (n=19) and as a prophylaxis in 8% (n=6). Vancomycin utilization was considered appropriate based on the CDC recommendations in 48 (65%) patients. Forty-seven (64%) patients received an appropriate dose regimen based on weight, age and creatinine clearance. Only 31% (n=23) of patients had both peak and trough levels taken around the third dose. In the post-intervention period, vancomycin was used as specific therapy in 41% (n=14) and empirically in 59% (n=20). Compliance with guidelines for empirical use of vancomycin improved from 21% in the pre-intervention phase to 85% after the intervention (P=.0001). In addition, compliance with vancomycin use in specific therapy was 100% compared to 82%. Compliance rate with vancomycin trough level monitoring increased from 35% in the pre-intervention period to 67.7% in the post-intervention period (P=0.0002).

Conclusion

In conclusion, in addition to the utilization of CDC based criteria for vancomycin, we had shown that patient's chart review by a clinical pharmacists with a feed back to the physicians when guidelines were not met coupled with and educational efforts are effective methods to decrease inappropriate vancomycin usage.

Keywords: Vancomycin, Infection, Guidelines, Antimicrobial use, Educational activity

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1876-0341(09)00052-5

doi:10.1016/j.jiph.2009.07.002

Journal of Infection and Public Health
Volume 2, Issue 3 , Pages 141-146, 2009